Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Grifols
Grifols
Activities:
Manufacturing
Ingredients
Research & Development
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Regulatory
Grifols Procleix ArboPlex arbovirus screening assay receives CE mark
The assay can detect four major arboviruses: chikungunya, dengue, West Nile and Zika
Manufacturing
Spanish technology collaboration focuses on manufacturing equipment
Grifols and Mondragon will work on jointly developing medical and pharmaceutical-related automation, robotics and instrumentation
Manufacturing
Grifols to exhibit at CPhI Worldwide 2017
Grifols Partnership is a business to business contract development and manufacturing platform that specialises in small molecules intravenous solutions for the pharmaceutical industry
Design & Build
Grifols opens US$100m worldwide operations facility in Dublin, Ireland
Will contain a warehouse and handle labelling, packaging and final conditioning for plasma, intermediate and finished product
Design & Build
ISD completes cold storage facility for Spanish pharmaceutical firm Grifols
The 12-month project involved the design and construction of two temperature-controlled self-supporting structures
Manufacturing
FOYA projects enhanced with GEA Technology
The company supplies equipment to three winners at the ISPE awards
Manufacturing
Grifols opens US$370m plasma production plant in Clayton, NC in the US
The North Fractionation Facility will produce six million litres of plasma a year by 2015
Subscribe now